NGM Biopharmaceuticals
Presence
NGM Biopharmaceuticals is one of the...
NGM Biopharmaceuticals is a company listed under the stock ticker NGM (US).
Executives
View the org chart displaying its 52 main executives
Most searched biographies at NGM Biopharmaceuticals
- David Woodhouse, Chief Executive Officer and Director
- William Rieflin, Chairman of the Board
- Shelly Guyer, Director
Popular executive movements at NGM Biopharmaceuticals
- Jean-Frédéric Viret has joined the company as Chief Financial Officer (posted on November 3 2023).
- Irene Perlich, who was Vice President and Corporate Controller, is promoted to Principal Accounting Officer and Vice President and Corporate Controller (posted on August 14 2023).
Create your alert
to follow the executive moves at NGM Biopharmaceuticals.
Biotechnology
NGM Biopharmaceuticals has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by NGM Biopharmaceuticals
- NGM Bio Appoints Siobhan Nolan Mangini to President and Chief Financial Officer | NGM Biopharmaceuticals, Inc.
- NGM Bio to Host the Final of Four Virtual R&D Events on June 29, 2022 | NGM Biopharmaceuticals, Inc.
- NGM Bio to Participate in Upcoming Investor Conferences | NGM Biopharmaceuticals, Inc.
- NGM Bio to Host the Third of Four Virtual R&D Events on May 31, 2022 | NGM Biopharmaceuticals, Inc.
- NGM Bio Announces Initiation of Phase 1/1b Clinical Study of NGM438 for the Treatment of Patients with Advanced Solid Tumors | NGM Biopharmaceuticals, Inc.
- NGM Bio Provides Business Highlights and Reports First Quarter 2022 Financial Results | NGM Biopharmaceuticals, Inc.
- News | NGM Biopharmaceuticals, Inc.
- News | NGM Biopharmaceuticals, Inc.
- NGM Bio to Participate in Upcoming Investor Conferences | NGM Biopharmaceuticals, Inc.
- NGM Bio to Host the Second of Four Virtual R&D Events on April 27, 2022 | NGM Biopharmaceuticals, Inc.
- View more press releases Close
Social media about NGM Biopharmaceuticals
- NGM Biopharmaceuticals on Wikipedia, Google News & Yahoo Finance
- NGM Biopharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including David Woodhouse 
Call NGM Biopharmaceuticals at +1 650...
